Previous close | 16.96 |
Open | 16.97 |
Bid | 17.04 x 400 |
Ask | 17.07 x 800 |
Day's range | 16.97 - 17.19 |
52-week range | 6.36 - 17.48 |
Volume | |
Avg. volume | 1,552,153 |
Market cap | 3.542B |
Beta (5Y monthly) | 1.50 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.54 |
Earnings date | 11 Nov 2024 - 15 Nov 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 18.17 |
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd. (Nasdaq: CLBT) (“Cellebrite,” the “Company” or “we”), a global leader in premier Digital Investigative solutions for the public and private sectors, announced today the “Redemption Fair Market Value” in connection with its previously announced redemption of its warrants (the “Warrants”) to purchase ordinary shares of the Company (the “Ordinary Shares”). On August 15, 2024, the Company announced that
In the last week, the United States market has been flat, but it has risen 25% over the past 12 months and earnings are expected to grow by 15% per annum in the next few years. In this favorable environment, identifying high growth tech stocks that align with these trends can offer significant opportunities for investors.
Cellebrite DI ( NASDAQ:CLBT ) Second Quarter 2024 Results Key Financial Results Revenue: US$92.2m (up 23% from 2Q...